A-Methylacyl coenzyme A racemase is highly expressed in the intestinal-type adenocarcinoma and high-grade dysplasia lesions of the stomach

Histology and Histopathology

Volumn 23, Issue 11, 2008, Pages 1315-1320

  Huang, Wenbin ^a   Zhao, Jianhua ^a   Li, Li ^a   Huang, Yue ^a   Yang, Xiaobin ^a   Wang, Jinsong ^a   Zhang, Tonghai ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

AMACR; Dysplasia; Gastric carcinoma; High grade; Low grade

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; AVIDIN; BIOLOGICAL MARKER; BIOTIN; PARAFFIN; ALPHA-METHYLACYL-COA RACEMASE; ISOMERASE; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; STOMACH ADENOCARCINOMA; STOMACH BIOPSY; STOMACH CARCINOGENESIS; STOMACH LESION; ADENOCARCINOMA; ADULT; AGED; CELL DIFFERENTIATION; CELL TRANSFORMATION; ENZYMOLOGY; FEMALE; HELICOBACTER PYLORI; ISOLATION AND PURIFICATION; MALE; METABOLISM; METAPLASIA; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PRECANCER; STOMACH MUCOSA; STOMACH TUMOR;

HELICOBACTER PYLORI;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GASTRIC MUCOSA; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; METAPLASIA; MIDDLE AGED; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; RACEMASES AND EPIMERASES; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 58149137031     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Amery L., Fransen M., De Nys K., Mannaerts G.P. and Van Veldhoven P.P. (2000). Mitochondrial and peroxisomal targeting of 2-methylacyl-CoA racemase in humans. J. Lipid Res. 41, 1752-1759.
2. Bajtai A. and Hidvegi J. (1998). The role of gastric mucosal dysplasia in the development of gastric carcinoma. Pathol. Oncol. Res. 4, 297-300.
3. Cho E.Y., Kim K.M., Park C.K., Kim J.J., Sohn T.S. and Kim D.W. (2007). AMACR is highly expressed in gastric adenomas and intestinal-type carcinomas. APMIS 115, 713-718.
4. Correa P. (1992). Human gastric carcinogenesis: a multistep and multifactorial process? first American Cancer Society Award Lecture on cancer epidemiology and prevention. Cancer Res. 52, 6735-6740.
5. Delchier J.C., Ebert M. and Malfertheiner P. (1998). Helicobacter pylori in gastric lymphoma and carcinoma. Curr. Opin. Gastroenterol. 14, 41-45.
6. Dixon M.F. (2002). Gastrointestinal epithelial neoplasia: Vienna revisited. Gut 51,130-131.
7. Dorer R.K., Glickman J.N., Blount P.L., Ayub K., Reid B. and Odze R.D. (2005). Immunostaining for AMACR is useful in distinguishing reactive from dysplastic epithelium in Barrett's esophagus and inflammatory bowel disease. Mod. Pathol. 18 (Suppl 1), 102A.
8. Dorer R. and Odze R.D. (2006). AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease. Am. J. Surg. Pathol. 30, 871-877.
9. Ferdinandusse S., Denis S., Clayton P.T., Graham A., Rees J.E., Allen J.T., McLean B.N., Brown A.Y., Verken P., Waterham H.R. and Wanders R.J. (2000). Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy. Nat. Genet. 24, 188-191.
10. Fuchs C.S. and Mayer R.J. (1995). Gastric carcinoma. N. Engl. J. Med. 333, 32-41.
11. Hameed O. and Humphrey P.A. (2005). Immunohistochemistry in diagnostic surgical pathology of the prostate. Semin. Diagn. Pathol. 22, 88-104.
12. Jiang Z., Fanger G.R., Banner B.F., Woda B.A., Algate P., Dresser K., Xu J., Reed S.G., Rock K.L. and Chu P.G. (2003a). A dietary enzyme: alpha-methylacyl-CoA racemase/P504S is overexpressed in colon carcinoma. Cancer Detect. Prev. 27, 422-426.
13. Jiang Z., Fanger G.R., Woda B.A., Banner B.F., Algate P., Dresser K., Xu J. and Chu P.G. (2003b). Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: a study of 761 cases. Hum. Pathol. 34, 792-796.
14. Lisovsky M., Falkowski O. and Bhuiya T. (2006). Expression of a-methylacyl-coenzyme A racemase in dysplastic Barrett's esophagus. Hum. Pathol. 37, 1601-1606.
15. Liu Q., Teh M., Ito K., Shah N., Ito Y. and Yeoh K.G. (2007). CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer. Mod. Pathol. 20, 1286-1297.
16. Neugut A.I., Hayek M. and Howe G. (1996). Epidemiology of gastric cancer. Semin. Oncol. 23, 281-291.
17. Pagnini C. and Rugge M. (1985). Advanced gastric cancer and prognosis. Virchows Arch. (A). 406, 213-211.
18. Rugge M., Cassaro M., Di Mario F., Leo G., Leandro G., Russo V.M., Pennelli G., Farinati F. and Interdisciplinary Group on Gastric Epithelial Dysplasia (IGGED) (2003). The long term outcome of gastric non-invasive neoplasia. Gut 52, 1111-1116.
19. Schmitz W., Fingerhut R. and Conzelmann E. (1994). Purification and properties of an alpha-methylacyl-CoA racemase from rat liver. Eur. J. Biochem. 222, 313-323.
20. Tahara E., Semba S. and Tahara H. (1996). Molecular biological observations in gastric cancer. Semin. Oncol. 23, 307-315.
21. To K.F., Leung W.K., Lee T.L., Yu J., Tong J.H., Chan M.W., Ng E.K., Chung S.C. and Sung J.J. (2002). Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. Int. J. Cancer 102, 623-628.
22. Uemura N., Okamoto S., Yamamoto S., Matsumura N., Yamaguchi S., Yamakido M., Taniyama K., Sasaki N. and Schlemper R.J. (2001). Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 345, 784-789.
23. Warren J.R. and Marshall B. (1983). Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet i, 1273-1275.
24. Xu J., Stolk J.A., Zhang X., Sliva S.J., Houghton R.L., Matsumura M., Vedvick T.S., Leslie K.B., Badaro R. and Rees S.G. (2000). Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res. 60, 1677-1682.